Tongjitang Chinese Medicines Company Reports Q4 EPS of $0.08
By Benzinga Staff
March 25, 2011 4:02 PM
March 25, 2011 4:02 PM
Tongjitang Chinese Medicines Company (NYSE: TCM) today announced its financial results for the quarter ended December 31, 2010.
Net revenue from continuing operations(i) increased 33.6% to RMB 188.8 million ($28.6 million)(ii), from RMB 141.3 million in the prior year period.
Total net income attributable to the Company was RMB 13.0 million ($2.0 million), which yielded earnings per ADS of RMB 0.50 ($0.08) and earnings per share of RMB 0.13 ($0.02).
Non-GAAP adjusted EBITDA per share was RMB 0.25 ($0.04), compared to RMB 0.14 in the fourth quarter of 2009.
(c) 2012 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We're Loving
